510 related articles for article (PubMed ID: 32663356)
1. Haematological manifestations of COVID-19: From cytopenia to coagulopathy.
Agbuduwe C; Basu S
Eur J Haematol; 2020 Nov; 105(5):540-546. PubMed ID: 32663356
[TBL] [Abstract][Full Text] [Related]
2. COVID-19-associated coagulopathy and disseminated intravascular coagulation.
Asakura H; Ogawa H
Int J Hematol; 2021 Jan; 113(1):45-57. PubMed ID: 33161508
[TBL] [Abstract][Full Text] [Related]
3. Thrombotic Complications of COVID-19 Infection: A Review.
Castro RA; Frishman WH
Cardiol Rev; 2021; 29(1):43-47. PubMed ID: 32947478
[TBL] [Abstract][Full Text] [Related]
4. Thromboelastography clot strength profiles and effect of systemic anticoagulation in COVID-19 acute respiratory distress syndrome: a prospective, observational study.
Bocci MG; Maviglia R; Consalvo LM; Grieco DL; Montini L; Mercurio G; Nardi G; Pisapia L; Cutuli SL; Biasucci DG; Gori C; Rosenkranz R; De Candia E; Carelli S; Natalini D; Antonelli M; Franceschi F
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12466-12479. PubMed ID: 33336766
[TBL] [Abstract][Full Text] [Related]
5. D-Dimer, Fibrinogen, and IL-6 in COVID-19 Patients with Suspected Venous Thromboembolism: A Narrative Review.
Eljilany I; Elzouki AN
Vasc Health Risk Manag; 2020; 16():455-462. PubMed ID: 33223833
[TBL] [Abstract][Full Text] [Related]
6. Complement activation and coagulopathy - an ominous duo in COVID19.
Tomo S; Kumar KP; Roy D; Sankanagoudar S; Purohit P; Yadav D; Banerjee M; Sharma P; Misra S
Expert Rev Hematol; 2021 Feb; 14(2):155-173. PubMed ID: 33480807
[TBL] [Abstract][Full Text] [Related]
7. Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation.
Gu SX; Tyagi T; Jain K; Gu VW; Lee SH; Hwa JM; Kwan JM; Krause DS; Lee AI; Halene S; Martin KA; Chun HJ; Hwa J
Nat Rev Cardiol; 2021 Mar; 18(3):194-209. PubMed ID: 33214651
[TBL] [Abstract][Full Text] [Related]
8. SARS-COV-2-associated coagulopathy and thromboembolism prophylaxis in children: A single-center observational study.
Del Borrello G; Giraudo I; Bondone C; Denina M; Garazzino S; Linari C; Mignone F; Pruccoli G; Scolfaro C; Spadea M; Pollio B; Saracco P
J Thromb Haemost; 2021 Feb; 19(2):522-530. PubMed ID: 33305475
[TBL] [Abstract][Full Text] [Related]
9. Hematological findings and complications of COVID-19.
Terpos E; Ntanasis-Stathopoulos I; Elalamy I; Kastritis E; Sergentanis TN; Politou M; Psaltopoulou T; Gerotziafas G; Dimopoulos MA
Am J Hematol; 2020 Jul; 95(7):834-847. PubMed ID: 32282949
[TBL] [Abstract][Full Text] [Related]
10. Coagulation and anticoagulation in COVID-19.
Hadid T; Kafri Z; Al-Katib A
Blood Rev; 2021 May; 47():100761. PubMed ID: 33067035
[TBL] [Abstract][Full Text] [Related]
11. Coagulopathy in COVID-19: Manifestations and management.
Mucha SR; Dugar S; McCrae K; Joseph D; Bartholomew J; Sacha GL; Militello M
Cleve Clin J Med; 2020 Jul; 87(8):461-468. PubMed ID: 32409435
[TBL] [Abstract][Full Text] [Related]
12. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial.
Sholzberg M; Tang GH; Negri E; Rahhal H; Kreuziger LB; Pompilio CE; James P; Fralick M; AlHamzah M; Alomran F; Tseng E; Lim G; Lillicrap D; Carrier M; Áinle FN; Beckett A; da Costa BR; Thorpe K; Middeldorp S; Lee A; Cushman M; Jüni P
Trials; 2021 Mar; 22(1):202. PubMed ID: 33691765
[TBL] [Abstract][Full Text] [Related]
13. Covid-19-induced coagulopathy and observed benefits with anticoagulation.
Karimzadeh S; Dong V; Hassan OG; Raut A; Fouda A; Parrill A; Eaton K; Huy NT
Transfus Apher Sci; 2020 Dec; 59(6):102906. PubMed ID: 32778522
[No Abstract] [Full Text] [Related]
14. Approach to the Patient with COVID-19-Associated Thrombosis: A Case-Based Review.
Chen EC; Zon RL; Battinelli EM; Connors JM
Oncologist; 2020 Oct; 25(10):e1500-e1508. PubMed ID: 32881209
[TBL] [Abstract][Full Text] [Related]
15. Understanding the andromeda strain - The role of cytokine release, coagulopathy and antithrombin III in SARS-CoV2 critical illness.
Mir N; D'Amico A; Dasher J; Tolwani A; Valentine V
Blood Rev; 2021 Jan; 45():100731. PubMed ID: 32829961
[TBL] [Abstract][Full Text] [Related]
16. The Hyper-Inflammatory Response in Adults with Severe COVID-19 Pneumonia Differs from the Cytokine Storm of Hemophagocytic Syndrome.
Brikman S; Bieber A; Dori G
Isr Med Assoc J; 2020 Aug; 22(8):505-513. PubMed ID: 33236584
[TBL] [Abstract][Full Text] [Related]
17. COVID-19-associated coagulopathy: a concise review on pathogenesis and clinical implications.
Memar Montazerin S; Najafi H; Shojaei F; Chi G; Goudarzi S; Sharfaei S; Kahe F; Hassanzadeh S
Infez Med; 2021 Mar; 29(1):1-9. PubMed ID: 33664168
[TBL] [Abstract][Full Text] [Related]
18. The most important biomarker associated with coagulation and inflammation among COVID-19 patients.
Hong LZ; Shou ZX; Zheng DM; Jin X
Mol Cell Biochem; 2021 Jul; 476(7):2877-2885. PubMed ID: 33742367
[TBL] [Abstract][Full Text] [Related]
19. Coronavirus (COVID-19), Coagulation, and Exercise: Interactions That May Influence Health Outcomes.
Zadow EK; Wundersitz DWT; Hughes DL; Adams MJ; Kingsley MIC; Blacklock HA; Wu SSX; Benson AC; Dutheil F; Gordon BA
Semin Thromb Hemost; 2020 Oct; 46(7):807-814. PubMed ID: 32882720
[TBL] [Abstract][Full Text] [Related]
20. Systematic review of the prognostic utility of D-dimer, disseminated intravascular coagulation, and anticoagulant therapy in COVID-19 critically ill patients.
Moreno G; Carbonell R; Bodí M; Rodríguez A
Med Intensiva (Engl Ed); 2021; 45(1):42-55. PubMed ID: 32646669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
